1 Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L & Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism 2005 90 4019–4024. (doi:10.1210/jc.2004-2225)
2 Asvold BO, Vatten LJ, Nilsen TI & Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. European Journal of Endocrinology 2007 156 181–186. (doi:10.1530/eje.1.02333)
3 Asvold BO, Bjoro T, Nilsen TI & Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone 
4 Alvarez-Pedrerol M, Ribas-Fito N, Torrent M, Julvez J, Ferrer C & Sunyer J. TSH concentration within the normal range is associated with cognitive function and ADHD symptoms in healthy preschoolers. Clinical Endocrinology 2007 66 890–898. (doi:10. 1111/j.1365-2265.2007.02871.x)
5 Asvold BO, Bjoro T, Nilsen TI, Gunnell D & Vatten LJ. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Archives of Internal Medicine 2008 168 855–860. (doi:10.1001/ archinte.168.8.855)
6 Smith GD. Reflections on the limitations to epidemiology. Journal of Clinical Epidemiology 2001 54 325–331. (doi:10. 1016/S0895-4356(00)00334-6)
7 Smith GD & Ebrahim S. Mendelian randomisation: prospects, potentials and limitations. International Journal of Epidemiology 2004 33 30–42. (doi:10.1093/ije/dyh132)
8 Asvold BO, Bjoro T, Nilsen TI & Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Archives of Internal Medicine 2007 167 1428–1432. (doi:10.1001/archinte.167.13. 1428)
9 Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG & Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 2880–2888. (doi:10.1210/jc.2002- 021592)
10 Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG, Sestu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L, Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A, Mariotti S, Shuldiner AR, Cao A, Schlessinger D, Uda M, Abecasis GR, Nagaraja R, Sanna S & Naitza S. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. American Journal of Human Genetics 2008 82 1270–1280. (doi:10.1016/j.ajhg.2008. 04.019)
11 Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM & Frayling TM. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. Journal of Clinical Endocrinology and Metabolism 2008 93 3075–3081. (doi:10. 1210/jc.2008-0397)
12 Bender AT & Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacological Reviews 2006 58 488–520. (doi:10.1124/pr.58.3.5)
13 Lakics V, Karran EH & Boess FG. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 2010 59 367–374. (doi:10. 1016/j.neuropharm.2010.05.004)
14 Hayashi M, Matsushima K, Ohashi H, Tsunoda H, Murase S, Kawardada Y & Tanaka T. Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isoenzyme of 3 0 ,5 0 -cyclic nucleotide phosphodiesterase. Biochemical and Biophysical Research Communications 1998 250 751–756. (doi:10.1006/bbrc.1998. 9379)
15 Hayashi M, Shimada Y, Nishimura Y, Hama T & Tanaka T. Genomic organization, chromosomal localization, and alternative 
16 Persani L, Borgato S, Lania A, Filopanti M, Mantovani G, Conti M & Spada A. Relevant cAMP specific phosphodiesterase isoforms in human pituitary: effect of Gs (alpha) mutations. Journal of Clinical Endocrinology and Metabolism 2001 86 3795–3800. (doi:10. 1210/jc.86.8.3795)
17 Shields BM, Freathy RM, Knight BA, Hill A, Weedon MN, Frayling TM, Hattersley AT & Vaidya B. Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. Journal of Clinical Endocrinology and Metabolism 2009 94 4608–4612. (doi:10.1210/jc.2009-1298)
18 Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ & O’Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community- based cohort using current immunoassay techniques. Journal of Clinical Endocrinology and Metabolism 2010 95 1095–1104. (doi:10.1210/jc.2009-1977)
19 Hwang SJ, Yang Q, Meigs JB, Pearce EN & Fox CS. A genome-wide association for kidney function and endocrine-related traits in the NHLBI’s Framingham Heart Study. BMC Medical Genetics 2007 8 (Suppl 1) S10. (doi:10.1186/1471-2350-8-S1-S10)
20 Shields BM, Freathy RM, Knight BA, Hill A, Weedon MN, Frayling TM, Hattersley AT & Vaidya B. Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. Journal of Clinical Endocrinology and Metabolism 2009 94 4608–4612. (doi:10.1210/jc.2009-1298)
21 O’Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, Kaye J & Walsh JP. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clinical Endocrinology 2006 64 97–104. (doi:10.1111/j.1365-2265.2005.02424.x)
22 Saravanan P, Simmons DJ, Greenwood R, Peters TJ & Dayan CM. Partial substitution of thyroxine (T 4 ) with tri-iodothyronine in patients on T 4 replacement therapy: results of a large community-based randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 2005 90 805–812. (doi:10.1210/ jc.2004-1672)
23 Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R & Dayan CM. Psychological well-being in patients on ‘adequate’ doses of L -thyroxine: results of a large, controlled community- based questionnaire study. Clinical Endocrinology 2002 57 577–585. (doi:10.1046/j.1365-2265.2002.01654.x)
24 Horvath A, Faucz F, Finkielstain GP, Nikita ME, Rothenbuhler A, Almeida M, Mericq V & Stratakis CA. Haplotype analysis of the promoter region of phosphodiesterase type 8B (PDE8B) in correlation with inactivating PDE8B mutation and the serum thyroid-stimulating hormone levels. Thyroid 2010 20 363–367. (doi:10.1089/thy.2009.0260)
25 Saberi M & Utiger RD. Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. Journal of Clinical Endocrinology and Metabolism 1974 39 923–927. (doi:10.1210/jcem-39-5-923) 